Clinical Trial

Gastric Recalibration After Endoscopic Sleeve Gastroplasty

Study acronym: ESG-IRM
Recruiting
View on ClinicalTrials.gov →
Summary
Endoscopic sleeve gastroplasty (ESG) is a technique used for bariatric surgery, with results comparable to conventional surgery, in order to treat morbid obesity. It has also less risks of complications, and it is not an irreversible technique. It can be repeated overtime, regarding the evolution of the gastroplasty. There is little data in the literature on the effectiveness of endoscopic "revision". This study will assess the benefits and costs of a revision during the follow-up endoscopy.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2021-06-24; most recent amendment 2025-04-29.
Status change: Not Yet Recruiting → Recruiting 2021-07-26
Trial Details
NCT Number NCT04945473
Lead Sponsor IHU Strasbourg
Conditions Morbid Obesity
Enrollment 100 participants
Start Date 2021-07-13
Primary Completion 2026-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2025-05-01